Log in to save to my catalogue

Effectiveness of BNT162b2 and CoronaVac in children and adolescents against SARS-CoV-2 infection dur...

Effectiveness of BNT162b2 and CoronaVac in children and adolescents against SARS-CoV-2 infection dur...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_23a1d441f01646b9a69f773a5d336ed7

Effectiveness of BNT162b2 and CoronaVac in children and adolescents against SARS-CoV-2 infection during Omicron BA.2 wave in Hong Kong

About this item

Full title

Effectiveness of BNT162b2 and CoronaVac in children and adolescents against SARS-CoV-2 infection during Omicron BA.2 wave in Hong Kong

Publisher

London: Nature Publishing Group UK

Journal title

Communications medicine, 2023-01, Vol.3 (1), p.3-7, Article 3

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Background
The SARS-CoV-2 Omicron BA.2 subvariant replaced BA.1 globally in early 2022, and caused an unprecedented tsunami of cases in Hong Kong, resulting in the collapse of elimination strategy. Vaccine effectiveness (VE) of BNT162b2 and CoronaVac against BA.2 is unclear.
Methods
We utilize an ecological design incorporating population-...

Alternative Titles

Full title

Effectiveness of BNT162b2 and CoronaVac in children and adolescents against SARS-CoV-2 infection during Omicron BA.2 wave in Hong Kong

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_23a1d441f01646b9a69f773a5d336ed7

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_23a1d441f01646b9a69f773a5d336ed7

Other Identifiers

ISSN

2730-664X

E-ISSN

2730-664X

DOI

10.1038/s43856-022-00233-1

How to access this item